Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine–induced rat mammary gland tumors
- 1 December 1997
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 20 (4) , 348-354
Abstract
Activating mutations in and expression of the Ha‐ras gene were examined in benign and malignant female Sprague‐Dawley rat mammary gland tumors induced by the heterocyclic amine 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) and promoted by a diet high in polyunsaturated fat. Ha‐ras mutations were detected in codons 12 and 13 by selective polymerase chain reaction amplification of mutated sequences and nucleotide sequencing. The percentage of Ha‐ras mutations in carcinomas from PhIP‐treated rats was significantly higher in rats on a low‐fat diet than in rats on a high‐fat diet (82% (nine of 11) vs 26% (seven of 27), respectively, P < 0.01). In addition, whereas 56% of the carcinomas with Ha‐ras mutations from rats on a low‐fat diet carried double Ha‐ras mutations, none of the carcinomas from rats on a high‐fat diet had double mutations. Ha‐ras mutations were also detected in benign tumors (largely adenomas) induced by PhIP in rats on different diets; two of eight and three of four benign tumors examined from rats on low‐fat and high‐fat diets, respectively, had Ha‐ras mutations, suggesting that activating Ha‐ras mutations alone are not sufficient for PhIP‐induced tumors to become malignant. No differences were observed in the level of Ha‐ras mRNA expression in the different groups. In our animal model, a high‐fat diet increased the incidence and percentage of malignant PhIP‐induced mammary gland tumors yet decreased the percentage of carcinomas showing Ha‐ras mutations. Thus, the complement of genetic alterations associated with PhIP‐induced mammary gland carcinogenesis is probably altered by the level of dietary fat. Mol. Carcinog. 20:348–354, 1997.Keywords
This publication has 26 references indexed in Scilit:
- Arachidonic acid and free fatty acids as second messengers and the role of protein kinase CCellular Signalling, 1995
- Ras may mediate mammary cancer promotion by high fatNutrition and Cancer, 1995
- Mutation and repair induced by the carcinogen 2-(Hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNAChemical Research in Toxicology, 1994
- Detection of Guanine-C8-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Adduct as a Single Spot on Thin-layer Chromatography by Modification of the32P-Postlabeling MethodJapanese Journal of Cancer Research, 1994
- Dose-dependence of 2-amino-1-methy1–6-phenylimidazo[4, 5-b]-pyridine (PhIP) carcinogenicity in ratsCarcinogenesis, 1993
- High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4, 5-f]quinolineCarcinogenesis, 1993
- Selective pressures and ras activation in carcinogenesisMolecular Carcinogenesis, 1992
- The Effect of GTPase Activating Protein Upon Ras Is Inhibited by Mitogenically Responsive LipidsScience, 1989
- Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in ratsNature, 1985
- Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutationsNature, 1983